Immunogenicity and safety of a DNA prime
β
Luigi Aurisicchio; Carmela Mennuni; Patrizia Giannetti; Francesco Calvaruso; Mau
π
Article
π
2007
π
John Wiley and Sons
π
French
β 875 KB
## Abstract Scaling up experimental protocols from rodents to humans is often not a straightforward procedure, and this particularly applies to cancer vaccines, where vaccination technology must be especially effective to overcome a variety of immune suppressive mechanisms. DNA electroporation (DNA